Home / Avalglucosidase Alfa / Belgium
BE ATC A16AB22 · updated 2 Nov 2026
Avalglucosidase Alfa shortage in Belgium
Is there an Avalglucosidase Alfa shortage in Belgium?
Yes. As of 2 Nov 2026, 3 Avalglucosidase Alfa products are reported short in Belgium, the first since 24 Mar 2025. The company estimate for the return is 6 Nov 2026 (latest 31 Dec 2027). Main reason: other.
Also short in Canada, Germany, France, Italy, Spain, Austria, Australia. All countries.
Affected products in Belgium
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| BE | Nexviadyme 100 mg inj. sol. (pwdr., conc.) i.v. vial 10 x 100 mg | Sanofi | 24 Mar 2025 | 31 Dec 2027 | Other Other reason |
| BE | Nexviadyme 100 mg inj. sol. (pwdr., conc.) i.v. vial 5 x 100 mg | Sanofi | 9 Apr 2025 | 31 Dec 2027 | Other Other reason |
| BE | Nexviadyme 100 mg inj. sol. (pwdr., conc.) i.v. vial 100 mg | Sanofi | 31 Aug 2026 | 6 Nov 2026 | Manufacturing problem Delay in the release of the end product |
Source
FAMHP (Federal Agency for Medicines and Health Products), PharmaStatus / SAMv2. Official list. All authorised packs with a declared temporary unavailability.